Drug Therapy Updates – MGH Clinical Trials Network and Institute

Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression

January 7, 2019/in Drug Therapy Updates /by mghctni

Salloum NC, Fava M, Freeman MP, et al. Efficacy of intravenous ketamine treatment in anxious
versus nonanxious unipolar treatment-resistant depression. Depress Anxiety. 2018;1–9. https://doi.org/10.1002/da.22875

Received: 23 July 2018 Revised: 3 October 2018 Accepted: 1 December 2018

Experimental medication treatment approaches for depression.

March 1, 2017/in Drug Therapy Updates /by mghctni

Ionescu DF, Papakostas GI.

Transl Psychiatry. 2017 Mar 21;7(3):e1068. doi: 10.1038/tp.2017.33. Review.

Antidepressant-like effect of low dose ketamine and scopolamine co-treatment in mice.

May 1, 2016/in Drug Therapy Updates /by mghctni

Petryshen TL, Lewis MC, Dennehy KA, Garza JC, Fava M.

Neurosci Lett. 2016 May 4;620:70-3. doi: 10.1016/j.neulet.2016.03.051.

Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder.

October 1, 2015/in Drug Therapy Updates /by mghctni

Papakostas GI, Ionescu DF.

Mol Psychiatry. 2015 Oct;20(10):1142-50. doi: 10.1038/mp.2015.92. Epub 2015 Jul 7. Review.

The American Society of Clinical Psychopharmacology survey of psychopharmacologists’ practice patterns for the treatment of mood disorders. Depress Anxiety.

August 1, 2015/in Drug Therapy Updates /by mghctni

Goldberg JF, Freeman MP, Balon R, Citrome L, Thase ME, Kane JM, Fava M.

2015 Aug;32(8):605-13. doi: 10.1002/da.22378. Epub 2015 Jun 30.

Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.

May 1, 2012/in Drug Therapy Updates /by mghctni

Taneja C, Papakostas GI, Jing Y, Baker RA, Forbes RA, Oster G.

Ann Pharmacother. 2012 May;46(5):642-9. doi: 10.1345/aph.1Q326. Epub 2012 May 1.

Archive for: Drug Therapy Updates